News from the BioRegion STERN

Here you'll find all press releases and news from companies and institutes in the STERN BioRegion.

02/12/2019 | Eberhard Karls Universität Tübingen

How sleep strengthens the immune system

Scientists at the University of Tübingen discover new mechanism that supports our immune system during sleep
02/04/2019 | CureVac AG

CureVac Appoints Stefan Mueller, Ph.D., as Vice President Preclinical

Drug development veteran to focus on advancing the company’s preclinical portfolio of programs in naturally optimized mRNA
02/01/2019 | Eberhard Karls Universität Tübingen

Novel unusual sugar from cyanobacteria acts as natural herbicide

Chemists and microbiologists at Tübingen University discover sugar molecule that inhibits the growth of plants and microorganisms and is harmless to human cells ‒ An alternative to controversial glyphosate?
01/28/2019 | Eberhard Karls Universität Tübingen

A safer way to correct faulty DNA

University of Tübingen researchers take RNA editing a step closer to treating hereditary diseases

CureVac Appoints Dimitris Voliotis, M.D., Dr. med., as Chief Development Officer

Drug development veteran to lead CureVac’s global product development efforts as the company looks to advance its pipeline of mRNA-based products
01/21/2019 | Fraunhofer-Institut für Produktionstechnik und Automatisierung IPA

From Stuttgart to the world: Fraunhofer IPA turns 60

"Future is our product" is the motto of the Fraunhofer Institute for Manufacturing Engineering and Automation IPA. The institute produces innovations and solutions for industrial applications and bridges the gap between science and practice. This is to be celebrated in 2019: 60 years ago – on July 1st, 1959 – the institute in Stuttgart began its wo...
12/10/2018 | Eberhard Karls Universität Tübingen

Bernd Engler re-elected as Tübingen University President

Senate and University Board confirm incumbent
11/21/2018 | Eberhard Karls Universität Tübingen

Researchers uncover camouflage strategy of multi-resistant bacteria

Breakthrough in the investigation of feared pathogens − Previously unknown protein in a key role
11/20/2018 | Universität Hohenheim

On its 200th Anniversary: Minister-President Commends University of Hohenheim’s Forward-Looking Focus

Winfried Kretschmann, Minister-President of Baden-Württemberg and graduate of the University of Hohenheim congratulates his alma mater / Fritz Kuhn, Lord Mayor of Stuttgart, sees University as an asset to the state capital
10/26/2018 | Universität Stuttgart

Against resistant germs: new research group

The growing numbers of resistant bacterial pathogenic agents and with this the increasing limitation of available active antibiotics poses one of the greatest challenges of the global health system. The research group “antibioPPAP”, funded for three years by the Ministry for Science and Culture from the State of Baden-Württemberg under the leadersh...
10/23/2018 | CureVac AG

CureVac Announces First Study Participant Enrolled in Phase I Clinical Trial Testing Prophylactic mRNA

Trial to provide first-in-human data for CureVac’s novel mRNA-based intramuscular rabies vaccine

How the immune system senses chitin, a key activator in fungal infections and dust allergies

University of Tübingen researchers identify chitin receptor – a first step towards treatments
10/16/2018 | Eberhard Karls Universität Tübingen

Antilock brake system in arteries protects against heart attack

Researchers at the University of Tübingen have discovered a natural mechanism that blocks the formation of dangerous blood clots

Personalized cancer therapy: B.Braun and CeGaT found joint venture CeCaVa

The medical technology and pharmaceutical manufacturer B. Braun Melsungen AG and CeGaT GmbH in Tübingen have announced the creation of the joint venture CeCaVa GmbH & Co. KG.
09/27/2018 | Eberhard Karls Universität Tübingen

Three new Clusters of Excellence for Tübingen

University takes next hurdle in the German government's Excellence Strategy funding program